TLDR More research is needed to better understand and treat Fibrosing Frontal Alopecia.
Fibrosing Frontal Alopecia (FFA) is a form of acquired primary cicatricial alopecia characterized by the recession of the frontotemporal hairline and often eyebrow alopecia. Its pathophysiology involves a combination of immunological, genetic, hormonal, and environmental factors, including photoexposure, cosmetic use, trauma, and stress. Diagnosis is primarily clinical, supported by physical examinations, trichoscopy, biopsy, and optical coherence tomography. The study concludes that, due to the novelty of FFA, further research is necessary to enhance understanding and develop more effective treatments.
May 2019 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.
17 citations
,
June 2016 in “Australasian Journal of Dermatology” Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.
9 citations
,
January 2020 in “Postepy Dermatologii I Alergologii” Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.
23 citations
,
April 2021 in “Journal of Clinical Medicine” Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.
3 citations
,
November 2020 in “Clinical, Cosmetic and Investigational Dermatology” Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.
June 2020 in “Journal of Drugs in Dermatology” Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.
12 citations
,
March 2018 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.